Hydrogen-generating silicon-based agent is effective in a mouse model of ovalbumin-induced allergic bronchial asthma.
In mice, si-based agents are effective against allergic bronchial asthma and may serve as superior materials for hydrogen therapy. These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
Read Article